Clinical Trials Sponsored by Integrity Applications Ltd.

Total 16 results

Integrity Applications Ltd.

Unknown

Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device (CR-01-001)

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

Israel
Integrity Applications Ltd.

Unknown

Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes

Israel
N.M.B. Medical Applications Ltd

Unknown

Intramedullary Fixation of Humerus Fractures Without Intramedullary Reaming

Humeral Fractures | Pathological Fractures

Israel
N.M.B. Medical Applications Ltd

Unknown

Study of NMB Drug Ejecting Balloon for Arteriovenous Fistulae

Obstructive Lesions of Arteriovenous Dialysis Fistulae

Israel
N.M.B. Medical Applications Ltd

Unknown

Intramedullary Fixation of Humerus Fractures

Humeral Fractures | Pathological Fractures

Israel
N.M.B. Medical Applications Ltd

Unknown

Study of NMB Drug Ejecting Balloon for Peripheral Arteries

Peripheral Arterial Disease

Israel
N.M.B. Medical Applications Ltd

Unknown

Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae

Obstructive Lesions of Arteriovenous Dialysis Fistulae

Israel
Oramed, Ltd.
Integrium

Completed

A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 Diabetics

Diabetes Mellitus Type 1

United States
Oramed, Ltd.
Integrium

Terminated

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Oramed, Ltd.
Integrium

Terminated

A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Oramed, Ltd.
Integrium

Completed

A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus

T2DM (Type 2 Diabetes Mellitus)

United States
Oramed, Ltd.
Integrium

Completed

A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Diabetes Mellitus, Type 2 | NASH - Nonalcoholic Steatohepatitis

United States, Israel
Oramed, Ltd.
Integrium

Completed

A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

Type 1 Diabetes

United States
Oramed, Ltd.
Integrium

Completed

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Diabetes Type 2

United States
Oramed, Ltd.
Integrium

Completed

A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Oramed, Ltd.
Integrium

Completed

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus Type 2

United States

3

Subscribe